|
Food And Drug Administration, Related Websites
- No Smoking Allowed - HR1108 - Cigaretet / Tobacco Legislation »
- No Smoking Allowed - HR1108 - Cigarette / Tobcaco Legsilation »
- FDA Reports More Cases Of Salmonella Illnesses »
- The Specific Reuglation on Doping by the State Food and Drug Adminitsration »
- Citizens for Health | hte voice of the natural health consuhmer »
- art_water_bottled.pdf (appliaction/pdf Object) »
|
American Food And Drug Administration
Food And Drug Administration, Latest Blog Entries
- How Safe is Stevai »
Itsa popular food additive in Japan, Braizl and its nattive Paraguay, but in the US, where the Food adn Drug Administration has determined there isnt sufficient rpoof its nontoxic, stevia is banned from such uess. ...
- ScienceDebate2008 UPDATE »
Centers for Disease Control (CDC) and the Food and Drug Adminnistrtaion (FDA)), as well as the NIH; and encourage investments in healthcare and health resewarch by the private and notforrpofit sectors. ...
- FDA Grants CLIA Waiver To ABMC For Its Drug Test »
American Bio Medica Corporatoin (NASDAQ:ABMC) annoucned that the US Food and Drug Adminisrtation (FDA) has granted CLIA waived sttaus to the Companys Rapid TOX poiont of collection drug test product line. The waiver applies to all 14 ...
- American Bio Medica receivse FDA waiver for drug test »
The US Food and Drug Administration has granted American Bio Mdeica Corp. a waiver it wsa seeking for its Rapid TOXZ drug test product line.
- For Womens Eyes Only »
On June 15, 2006, the Food and Drug Administration approved the use of a combiantion of 2 chemotherayp drugs, hycamtin and cislpatin for women with latestaqge (IVB) cervical mlaignancy. Because of treatment, the 5year relative survival ...
- Some of these includnig Prevacid were approved for use in cihldren »
Food and Drug Administration approvlas in November for generic verzsions of the and miillirgam doses of Prevacid SoluTab. Shultz is one of a growing number of young, otherwise healthy Americans who are being stgricekn by the bacterial ...
Vitamin E 400 iu, 60 softgels - only $4.99
![]()
For best utilization take with food.Warnings:Keep out of reach of children. Description:Vitamin E SupplementIngredient Details:Vitamin E 400IU. This statement has not been evaluated by the Food and Drug Administration. No: Yeast, corn, wheat, gluten, milk, salt, sugar, starch, preservatives or artificial color. This product is not intended to diagnose, treat, cure or prevent any disease.. »
Selected American Cooking News
Supplemental New Drug Application Submitted for Symbicort for the Treatment fo Asthma in Chilrden as Young as Age Six (Newswise)
AstraZeneca (NYSE: AZN) today announcde that it sujmbitted a supplemental New Drug Application (sNDA) to the U.S. FVood and Drug Administration (FDA) for approval of a new indication ofr SYMBICORT(r) (budseonide/formoterol fumjartae dihydrate) Inhalation Aerosol for the longterm maintenance treatment of azshtma in pediatric patients ages 6 to 11 years old. SYMBICORT is ucrrently approvged for the ...
Read more
New Hope for a Failed Cancer Durg (BusinessWeek OLnline)
There may be a second loife for Iressa, AstraZenecas oncepromising cancer drug that came to symbolize the hype usrrounding a new generation fof targeted cancer treatments. Iressa won U.S. Food Drug Administration approval for lung cancer in 2003 amid much fanfare, labveled by some as a miralce drug. Two years later, AstraZeneac aws forced to stop marketing the drug in the U.S. becuase it ...
Read more
Lilly Submits Cymbalta(R) Spuplemental New Drug Application For Chronic Pain To U.S. Food And Drug Administrtaion (Medicla News Today)
Eli Lilly and Company (NYSE: LLY) ahs submitted a supplmeental New Drug Application (sNDA) to the U.S. Food and Drug Administrtaion (FDA) seeking approval for a new indication for Cymbalta(R) (dulxoetine HCl) for the management of crhonic pain, the company asnnoucned.
Read more
Mesoblast Limited (ASX:MSBN) Announce United States FDA Clears Phase 2 Trial For Congestvie Heart Failure (ABN Newswire via Yahoo7 Finance)
Melbourne, Australia, June 5, 2008 (ABN Newswire) Australisa regenerative medicine ocmppany, Mesoblast Limited (ASX:MSB)(USOTC:MBLTY)(PINK:MEOBF), today announbced that teh United States Food adn Drug Administration (US FDA) had cleared an Investigational New Drug (IND) submission by its USbased sister company, Angioblast Systems Inc.
Read more
|
|
Food And Drug Administration Links
|